HETLIOZ (TASIMELTEON) CAPSULES
Live / Registered — Registered (as of 28 Apr 2020)
What this means for you
Registered since 28 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88366693
- Registration number
- 6040230
- Mark type
- Design + words
- Filed
- 01 Apr 2019
- Published for opposition
- 16 Jul 2019
- Registered
- 28 Apr 2020
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prior registrations
Prosecution history
- 27 Mar 2026 — TEAS SECTION 8 & 15 RECEIVED
- 28 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 03 Mar 2020 — NOTICE OF ALLOWANCE CANCELLED
- 25 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Mar 2020 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 10 Sept 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2019 — PUBLISHED FOR OPPOSITION
- 26 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2019 — ASSIGNED TO EXAMINER
- 20 Apr 2019 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 19 Apr 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED